Related references
Note: Only part of the references are listed.The evolving indications for splenectomy
Matthew G. Browning et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
The use of thrombopoietin-receptor agonists (TPO-RAs) in immune thrombocytopenia (ITP): a real life retrospective multicenter experience of the Rete Ematologica Pugliese (REP)
Patrizio Mazza et al.
ANNALS OF HEMATOLOGY (2016)
Overwhelming Postsplenectomy Infection: A Prospective Multicenter Cohort Study
Christian Theilacker et al.
CLINICAL INFECTIOUS DISEASES (2016)
Clinical Outcome and Predictive Factors in the Response to Splenectomy in Elderly Patients with Primary Immune Thrombocytopenia: A Multicenter Retrospective Study
Young Hoon Park et al.
ACTA HAEMATOLOGICA (2016)
Characteristics, outcome, and response to therapy of multirefractory chronic immune thrombocytopenia
Matthieu Mahevas et al.
BLOOD (2016)
Current Management of Primary Immune Thrombocytopenia
Drew Provan et al.
ADVANCES IN THERAPY (2015)
A review of guidance on immunization in persons with defective or deficient splenic function
Ernest Kuchar et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Management of immune thrombocytopenia in adults: a population-based analysis of the French hospital discharge database from 2009 to 2012
Marc Michel et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Late Results After Splenectomy in Adult Idiopathic Thrombocytopenic Purpura
Rosario Vecchio et al.
JSLS-JOURNAL OF THE SOCIETY OF LAPAROENDOSCOPIC SURGEONS (2015)
Rituximab as second-line treatment for adult immune thrombocytopenia (the RITP trial): a multicentre, randomised, double-blind, placebo-controlled trial
Waleed Ghanima et al.
LANCET (2015)
Treatment of Immune Thrombocytopenia in Adults: The Role of Thrombopoietin-Receptor Agonists
Francesco Rodeghiero et al.
SEMINARS IN HEMATOLOGY (2015)
Does the site of platelet sequestration predict the response to splenectomy in adult patients with immune thrombocytopenic purpura?
Julie Navez et al.
PLATELETS (2015)
Rituximab versus splenectomy in persistent or chronic adult primary immune thrombocytopenia: an adjusted comparison of mortality and morbidity
Guillaume Moulis et al.
AMERICAN JOURNAL OF HEMATOLOGY (2014)
Splenectomy and the Risk of Sepsis A Population-Based Cohort Study
Gustaf Edgren et al.
ANNALS OF SURGERY (2014)
Safety and efficacy of rituximab in adult immune thrombocytopenia: results from a prospective registry including 248 patients
Mehdi Khellaf et al.
BLOOD (2014)
Thrombotic risk in patients with primary immune thrombocytopenia is only mildly increased and explained by personal and treatment-related risk factors
M. Ruggeri et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2014)
Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study
Mansoor N. Saleh et al.
BLOOD (2013)
Splenectomy and the incidence of venous thromboembolism and sepsis in patients with immune thrombocytopenia
Soames Boyle et al.
BLOOD (2013)
Splenectomy as a curative treatment for immune thrombocytopenia: a retrospective analysis of 233 patients with a minimum follow up of 10 years
Nicola Vianelli et al.
HAEMATOLOGICA (2013)
Pathophysiology and management of primary immune thrombocytopenia
Hirokazu Kashiwagi et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2013)
Long-term Relapse-free Rurvival Rate and Predictive Factors of Idiopathic Thrombocytopenic Purpura in Adults Undergoing Splenectomy
Ta-Sen Yeh et al.
Biomedical Journal (2013)
Outcomes and complications after splenectomy for hematologic disorders
Nirav Y. Patel et al.
AMERICAN JOURNAL OF SURGERY (2012)
A pilot randomized trial of adjuvant rituximab or placebo for nonsplenectomized patients with immune thrombocytopenia
Donald M. Arnold et al.
BLOOD (2012)
How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatment
Waleed Ghanima et al.
BLOOD (2012)
Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia
Vivek L. Patel et al.
BLOOD (2012)
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia
Cindy Neunert et al.
BLOOD (2011)
Risk of venous thromboembolism in patients with primary chronic immune thrombocytopenia: a Danish population-based cohort study
Marianne T. Severinsen et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Durability and factors associated with long term response after splenectomy for primary immune thrombocytopenia (ITP) and outcome of relapsed or refractory patients
Aamer Aleem
PLATELETS (2011)
Should medical treatment options be exhausted before splenectomy is performed in adult ITP patients? A debate
Roberto Stasi et al.
ANNALS OF HEMATOLOGY (2010)
International consensus report on the investigation and management of primary immune thrombocytopenia
Drew Provan et al.
BLOOD (2010)
Contributions of TRAIL-mediated megakaryocyte apoptosis to impaired megakaryocyte and platelet production in immune thrombocytopenia
Lei Yang et al.
BLOOD (2010)
Autologous 111In-labelled platelet sequestration studies in patients with primary immune thrombocytopenia (ITP) prior to splenectomy: a report from the United Kingdom ITP Registry
Ameet Sarpatwari et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Romiplostim or Standard of Care in Patients with Immune Thrombocytopenia.
David J. Kuter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Risk for Hospital Contact With Infection in Patients With Splenectomy A Population-Based Cohort Study
Reimar W. Thomsen et al.
ANNALS OF INTERNAL MEDICINE (2009)
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group
Francesco Rodeghiero et al.
BLOOD (2009)
The ITP syndrome: pathogenic and clinical diversity
Douglas B. Cines et al.
BLOOD (2009)
Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial
James B. Bussel et al.
LANCET (2009)
Historical review. The light and shadow of Paul Kaznelson: his life and contribution to hematology
Yataro Yoshida
ANNALS OF HEMATOLOGY (2008)
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura:: a double-blind randomised controlled trial
David J. Kuter et al.
LANCET (2008)
Prediction of response to splenectomy in patients with idiopathic thrombocytopenic purpura
A. Shojaiefard et al.
WORLD JOURNAL OF SURGERY (2008)
Late spontaneous remissions in severe adult autoimmune thrombocytopenia
R. Simanek et al.
ANNALS OF HEMATOLOGY (2007)
Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications
K Kojouri et al.
BLOOD (2004)
Overwhelming infection in asplenic patients: current best practice preventive measures are not being followed
DJ Waghorn
JOURNAL OF CLINICAL PATHOLOGY (2001)
Share Paper
